Ani Pharmaceuticals (ANIP) Acquisitions (2018 - 2024)
Ani Pharmaceuticals' (ANIP) quarterly Acquisitions came in at $8.2 million in Q4 2024, down 90.29% quarter-over-quarter from $84.5 million in Q4 2021.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Acquisitions (2018 - 2024) Analysis & Trends
Ani Pharmaceuticals has disclosed Acquisitions across 3 years of filings, most recently posting $8.2 million for Q4 2024.
- In Q4 2024, Acquisitions changed N/A year-over-year to $8.2 million; the TTM figure through Dec 2025 stood at $8.2 million (changed 0.0% YoY), while the FY2024 annual figure was $401.3 million, changed N/A from the prior year.
- Acquisitions came in at $8.2 million for Q4 2024 at Ani Pharmaceuticals, down from $84.5 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $84.5 million in Q4 2021 to a low of $8.2 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2.32 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 8.20 Mn |
| Dec 31, 2021 | 84.49 Mn |
| Dec 31, 2018 | -600,000.00 |